香港小轮(集团)(00050) - 2023 - 年度业绩

Financial Performance - The group's revenue for the year was approximately HKD 375 million, representing a 33.5% increase compared to the previous year, primarily due to increased interest income[17] - The net profit after tax for the year was approximately HKD 186 million, a decrease of about 86% compared to the same period in 2022, mainly due to the absence of revenue from the "Imperial" joint development project[30] - The earnings per share for the year were HKD 0.53, compared to HKD 3.65 in 2022[30] - For the fiscal year ending December 31, 2023, the company reported a profit of HKD 185,866,000, a significant decrease from HKD 1,299,136,000 in the previous year, representing a decline of approximately 85.7%[40] - Total revenue for the year was HKD 374,605,000, up from HKD 280,632,000 in 2022, indicating an increase of about 33.5%[40] - Operating profit for the year was HKD 174,325,000, slightly down from HKD 176,345,000 in the previous year, reflecting a decrease of approximately 1.1%[40] - Total comprehensive income for the year was HKD 185,725,000, down from HKD 1,302,807,000 in 2022, a decrease of approximately 85.7%[41] Assets and Liabilities - As of December 31, 2023, total assets amounted to HKD 7,048,545,000, a decrease from HKD 7,303,688,000 in the previous year, representing a decline of about 3.5%[42] - The company's net asset value as of December 31, 2023, was HKD 6,964,640,000, down from HKD 7,218,257,000 in 2022, indicating a decrease of approximately 3.5%[42] - The company's total liabilities as of December 31, 2023, were HKD 409,715,000, compared to HKD 53,441,000 in 2022, indicating a significant increase[93] - The group's total liabilities include a rental land price amortization of HKD 1,369,000, consistent with the previous year[62] - The total trade and other receivables as of December 31, 2023, amounted to HKD 57,669,000, up from HKD 53,784,000 in 2022, representing an increase of approximately 7.0%[9] Revenue Segments - The medical beauty clinic AMOUR, opened in August 2022, saw its revenue grow eightfold to HKD 2.76 million by December 2023, although it still reported a loss of HKD 30 million[15] - The revenue from the real estate investment segment was HKD 170,149,000 in 2023, up from HKD 160,034,000 in 2022, indicating a growth of about 6.6%[79] - The healthcare and beauty services segment generated revenue of HKD 166,040,000 in 2023, compared to HKD 123,434,000 in 2022, reflecting a significant increase of approximately 34.4%[79] - The group's rental income from shops in 2023 was approximately HKD 122 million, with full occupancy for "Bright Residence" and "City Center" shops, and an occupancy rate of 89% for "Jiaxian Residence" shops[100] Corporate Governance and Compliance - The group has maintained high corporate governance standards and complied with the Corporate Governance Code during the reporting period[23] - The company did not apply retrospective changes to accounting policies due to the minimal impact of the removal of the offsetting mechanism on its financial results[37] - The group has not adopted any new accounting standards that are not yet effective during the current period, ensuring stability in financial reporting[46] Future Outlook and Developments - The group anticipates an increase in visitors to Hong Kong, benefiting various sectors including retail and hospitality, due to government support and relaxed travel restrictions[22] - The group plans to open a new clinic in "Harbour Plaza" in April 2024, expanding its pain management services with new medical equipment and professional therapists[104] - The local economy is gradually recovering, which is expected to benefit the group's business and support stable development[134] Employee and Operational Metrics - The group’s employee count increased to approximately 284, up from 250 in the previous year, with total employee costs around HKD 130 million[20] - The group has delivered 1,746 residential units to buyers, with 35 remaining units and parking spaces to be sold in batches[125] - The group is gradually expanding its medical specialty business, collaborating with ICON to establish a cancer center in Tsim Sha Tsui, which has been profitable since its mid-year opening[128] Other Financial Metrics - The group received government relief measures amounting to HKD 5,300,000 for the current year, compared to HKD 2,592,000 in the previous year, reflecting increased support due to the pandemic[60] - The total other income for the current period is HKD 83,723,000, down from HKD 150,482,000 in the previous year, indicating a decline of approximately 44.4%[50] - The group’s interest income from financial assets at fair value through profit or loss decreased to HKD 99,096,000 from HKD 110,569,000, a decline of about 10.3%[62] - The company recorded a decrease in interest income from HKD 79,400,000 in 2022 to HKD 10,296,000 in 2023, a decline of about 87.0%[84]